ANTHERA PHARMACEUTICALS
Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases. Its primary product candidates include varespladib methyl (A-002), which has completed its Phase 2 clinical studies for the treatment of acute coronary syndrome; varespladib sodium (A-001) that is in a Phase 2 clinical study for the prevention of acute chest syndrome a... ssociated with sickle cell disease; and A-623, which has completed Phase 1 clinical studies for the treatment of B-cell mediated autoimmune diseases. The company has license agreements with Eli Lilly and Company, and Shionogi & Co., Ltd. to develop and commercialize secretory phospholipase A2 or sPLA2 inhibitors for the treatment of cardiovascular disease and other diseases; and Amgen Inc., to develop and commercialize A-623. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.
ANTHERA PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2004-01-01
Address:
Hayward, California, United States
Country:
United States
Website Url:
http://www.anthera.com
Total Employee:
1+
Status:
Active
Contact:
510-856-5600
Email Addresses:
[email protected]
Total Funding:
101.5 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content ReCAPTCHA JsDelivr ReCAPTCHA V2 Hetzner
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arena Pharmaceuticals
Arena Pharmaceuticals is focused on delivering solutions for cardiovascular, central nervous system, inflammatory and metabolic diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Neuraltus Pharmaceuticals
Neuraltus Pharmaceuticals is focused on developing therapeutics that meet critical unmet needs in treating neurodegenerative diseases.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Synta Pharmaceuticals
Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Anthera Pharmaceuticals
OrbiMed
OrbiMed investment in Post-IPO Equity - Anthera Pharmaceuticals
Caxton Associates
Caxton Associates investment in Post-IPO Equity - Anthera Pharmaceuticals
Mitsubishi International Corporation (MIC)
Mitsubishi International Corporation (MIC) investment in Venture Round - Anthera Pharmaceuticals
HBM Healthcare Investments
HBM Healthcare Investments investment in Venture Round - Anthera Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Anthera Pharmaceuticals
Pappas Ventures
Pappas Ventures investment in Venture Round - Anthera Pharmaceuticals
Caxton Advantage Life Sciences Fund
Caxton Advantage Life Sciences Fund investment in Venture Round - Anthera Pharmaceuticals
VantagePoint Capital Partners
VantagePoint Capital Partners investment in Venture Round - Anthera Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Anthera Pharmaceuticals
Official Site Inspections
http://www.anthera.com
- Host name: h7.hostdl.com
- IP address: 148.251.116.174
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Anthera Pharmaceuticals"
Anthera Pharmaceuticals - Wikipedia
Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase (Sollpura), Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency (EPI) is currently in Phase 3 clinical trials, and A-623 (Blisibimod) for the treatment of IgA nephropathy is currently in Phase 2 clinical …See details»
Anthera Pharmaceuticals - Crunchbase Company …
Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases …See details»
Anthera Pharmaceuticals Company Description - Stock Analysis
Apr 16, 2025 Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It …See details»
Anthera Company Profile | Management and Employees List
Anthera Profile and History. Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions …See details»
Anthera Pharmaceuticals Inc (ANTH) Profile - The Globe and Mail
See the company profile for Anthera Pharmaceuticals Inc (ANTH) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Anthera Pharmaceuticals - Contacts, Employees, Board Members, …
Anthera Pharmaceuticals has 6 current employee profiles, including President & CEO, Director Paul F. Truex. Anthera Pharmaceuticals has 11 board members and advisors, including Brian …See details»
Anthera Pharmaceuticals, Inc. (ANTH) - Yahoo Finance Canada
See the company profile for Anthera Pharmaceuticals, Inc. (ANTH) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Anthera Pharmaceuticals, Inc. (ANTH) - Yahoo Finance
See the company profile for Anthera Pharmaceuticals, Inc. (ANTH) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ...See details»
Anthera Pharmaceuticals | Gladeo
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet …See details»
ANTHERA PHARMACEUTICALS, INC.
ANTHERA PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 20-1852016 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. …See details»
Anthera Pharmaceuticals, Inc. - VentureRadar
Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. …See details»
Anthera Canada Inc. Company Profile | Montréal, QC, Canada ...
Find company research, competitor information, contact details & financial data for Anthera Canada Inc. of Montréal, QC. Get the latest business insights from Dun & Bradstreet.See details»
Anthera Pharmaceuticals - PitchBook
Anthera Pharmaceuticals General Information Description. Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat …See details»
Anthera Pharmaceuticals Inc. Company Profile & Executives - WSJ
Company profile for Anthera Pharmaceuticals Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed ANTH description & address.See details»
Anthera Pharmaceuticals - LinkedIn
Anthera is a pharmaceutical company dedicated to cultivating medical cannabis and producing end products providing alternative treatment ...See details»
Anthera Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Apr 7, 2025 At Peninsula Pharmaceuticals, she advanced novel antibiotics from pre-clinical studies to US FDA approval – Peninsula was acquired by Johnson and Johnson. As the Chief …See details»
Anthera - Overview, News & Similar companies | ZoomInfo.com
Jun 27, 2018 Anthera Pharmaceuticals to Present at the 30TH Annual ROTH Conference HAYWARD, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. …See details»
Anthera Pharmaceuticals - Craft
Oct 29, 2024 Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with …See details»
About Anthera (ANTH) - Investing.com
Anthera Pharmaceuticals, Inc. (Anthera) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, …See details»
Anthera - Company Information, Competitors, News & FAQs
Find useful insights on Anthera's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Anthera.See details»